Enzo Biochem, Inc. (ENZ)
USD 0.71
(0.73%)
USD 0.71
(0.73%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -8.34 Million USD | 60.14% |
| 2023 | -20.94 Million USD | -10.59% |
| 2022 | -15 Million USD | -187.45% |
| 2021 | 3.34 Million USD | 183.35% |
| 2020 | -27.58 Million USD | -118.52% |
| 2019 | -24.15 Million USD | -22.48% |
| 2018 | -3.9 Million USD | -2.87% |
| 2017 | 1.09 Million USD | 4.9% |
| 2016 | -6.56 Million USD | 5743.77% |
| 2015 | -1.2 Million USD | -250.5% |
| 2014 | -5.72 Million USD | 142.77% |
| 2013 | -14.29 Million USD | -120.89% |
| 2012 | -11.46 Million USD | 258.32% |
| 2011 | -8.35 Million USD | 39.23% |
| 2010 | -17.99 Million USD | 31.66% |
| 2009 | -20.01 Million USD | -60.43% |
| 2008 | -8.74 Million USD | 42.88% |
| 2007 | -19.77 Million USD | -18.11% |
| 2006 | -19.02 Million USD | 13.4% |
| 2005 | -7.97 Million USD | -122.63% |
| 2004 | -9.87 Million USD | -259.75% |
| 2003 | 6.17 Million USD | -44.56% |
| 2002 | 11.14 Million USD | -2.93% |
| 2001 | 11.48 Million USD | 63.8% |
| 2000 | 7 Million USD | 34.78% |
| 1999 | 5.2 Million USD | 550.0% |
| 1998 | 2.7 Million USD | 366.67% |
| 1997 | 1.5 Million USD | -104.76% |
| 1996 | 300 Thousand USD | 155.75% |
| 1995 | 100 Thousand USD | -707.14% |
| 1994 | 1.1 Million USD | 46.15% |
| 1993 | -3.6 Million USD | -244.44% |
| 1992 | 1.4 Million USD | -45.45% |
| 1991 | -1.4 Million USD | 12.5% |
| 1990 | -1.6 Million USD | 56.76% |
| 1989 | -3.7 Million USD | -54.17% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.15 Million USD | 79.11% |
| 2024 Q4 | -2.04 Million USD | -118.84% |
| 2024 Q1 | -1.72 Million USD | -131.18% |
| 2024 Q3 | -1.01 Million USD | -17.5% |
| 2023 FY | - USD | -10.59% |
| 2023 Q4 | 12.66 Million USD | 286.96% |
| 2023 Q1 | -6.17 Million USD | 65.35% |
| 2023 Q2 | -11.83 Million USD | -91.75% |
| 2023 Q3 | -6.77 Million USD | 42.78% |
| 2022 Q1 | 1.81 Million USD | 242.95% |
| 2022 FY | - USD | -187.45% |
| 2022 Q4 | -17.81 Million USD | -14945.0% |
| 2022 Q3 | 120 Thousand USD | -97.56% |
| 2022 Q2 | 4.92 Million USD | 171.33% |
| 2021 FY | - USD | 183.35% |
| 2021 Q3 | 4.89 Million USD | -22.35% |
| 2021 Q4 | -1.26 Million USD | -125.92% |
| 2021 Q1 | 2.6 Million USD | 196.37% |
| 2021 Q2 | 6.3 Million USD | 142.37% |
| 2020 FY | - USD | -118.52% |
| 2020 Q1 | -4.27 Million USD | -120.44% |
| 2020 Q4 | -2.69 Million USD | 43.76% |
| 2020 Q2 | 19.38 Million USD | 553.21% |
| 2020 Q3 | -4.79 Million USD | -124.76% |
| 2019 Q3 | -33.89 Million USD | -468.07% |
| 2019 Q1 | -2.28 Million USD | -109.35% |
| 2019 Q4 | 20.92 Million USD | 161.72% |
| 2019 Q2 | -5.96 Million USD | -161.02% |
| 2019 FY | - USD | -22.48% |
| 2018 Q3 | 1.78 Million USD | 381.35% |
| 2018 Q2 | 370 Thousand USD | -68.32% |
| 2018 Q1 | 1.16 Million USD | -95.85% |
| 2018 FY | - USD | -2.87% |
| 2018 Q4 | 24.45 Million USD | 1273.1% |
| 2017 Q4 | 28.17 Million USD | 4.0% |
| 2017 Q3 | 27.08 Million USD | 3560.68% |
| 2017 FY | - USD | 4.9% |
| 2017 Q2 | 740 Thousand USD | -4.39% |
| 2017 Q1 | 774 Thousand USD | -97.09% |
| 2016 Q4 | 26.6 Million USD | 1960.65% |
| 2016 Q1 | -4.68 Million USD | 52.1% |
| 2016 Q3 | 1.29 Million USD | 113.34% |
| 2016 FY | - USD | 5743.77% |
| 2016 Q2 | -9.68 Million USD | -106.79% |
| 2015 Q4 | -9.77 Million USD | -651.21% |
| 2015 Q2 | 2.92 Million USD | -10.34% |
| 2015 FY | - USD | -250.5% |
| 2015 Q1 | 3.25 Million USD | 35.41% |
| 2015 Q3 | 1.77 Million USD | -39.3% |
| 2014 FY | - USD | 142.77% |
| 2014 Q1 | 470 Thousand USD | 248.26% |
| 2014 Q2 | 421 Thousand USD | -10.43% |
| 2014 Q3 | -2.08 Million USD | -596.2% |
| 2014 Q4 | 2.4 Million USD | 215.17% |
| 2013 FY | - USD | -120.89% |
| 2013 Q4 | -317 Thousand USD | 61.25% |
| 2013 Q3 | -818 Thousand USD | 59.68% |
| 2013 Q2 | -2.02 Million USD | 33.97% |
| 2013 Q1 | -3.07 Million USD | -114.1% |
| 2012 FY | - USD | 258.32% |
| 2012 Q4 | 21.79 Million USD | 941.62% |
| 2012 Q3 | -2.59 Million USD | -4.48% |
| 2012 Q2 | -2.47 Million USD | 21.99% |
| 2012 Q1 | -3.17 Million USD | -20.88% |
| 2011 Q4 | -2.62 Million USD | -85.27% |
| 2011 FY | - USD | 39.23% |
| 2011 Q3 | -1.41 Million USD | 68.38% |
| 2011 Q2 | -4.48 Million USD | -21271.43% |
| 2011 Q1 | -21 Thousand USD | 99.81% |
| 2010 Q4 | -10.92 Million USD | -226.11% |
| 2010 Q3 | -3.35 Million USD | -888.47% |
| 2010 FY | - USD | 31.66% |
| 2010 Q2 | 425 Thousand USD | 148.24% |
| 2010 Q1 | -881 Thousand USD | 79.76% |
| 2009 FY | - USD | -60.43% |
| 2009 Q2 | -6.94 Million USD | -41.91% |
| 2009 Q3 | -3.41 Million USD | 50.81% |
| 2009 Q4 | -4.35 Million USD | -27.5% |
| 2009 Q1 | -4.89 Million USD | -48.57% |
| 2008 Q2 | -4.83 Million USD | -100.66% |
| 2008 Q4 | -3.29 Million USD | -43.13% |
| 2008 FY | - USD | 42.88% |
| 2008 Q1 | -2.41 Million USD | 46.62% |
| 2008 Q3 | -2.3 Million USD | 52.44% |
| 2007 FY | - USD | -18.11% |
| 2007 Q4 | -4.51 Million USD | 10.33% |
| 2007 Q3 | -5.03 Million USD | 43.45% |
| 2007 Q2 | -8.9 Million USD | -52.44% |
| 2007 Q1 | -5.84 Million USD | -4.38% |
| 2006 FY | - USD | 13.4% |
| 2006 Q4 | -5.59 Million USD | -28.7% |
| 2006 Q3 | -4.34 Million USD | 20.89% |
| 2006 Q2 | -5.49 Million USD | -53.13% |
| 2006 Q1 | -3.58 Million USD | -10.08% |
| 2005 Q1 | -15.56 Million USD | -151.16% |
| 2005 FY | - USD | -122.63% |
| 2005 Q4 | -3.26 Million USD | -39.04% |
| 2005 Q3 | -2.34 Million USD | -193.13% |
| 2005 Q2 | -800 Thousand USD | 94.86% |
| 2004 Q3 | -609 Thousand USD | 74.91% |
| 2004 Q1 | -635 Thousand USD | 86.22% |
| 2004 FY | - USD | -259.75% |
| 2004 Q4 | -6.19 Million USD | -917.73% |
| 2004 Q2 | -2.42 Million USD | -282.2% |
| 2003 Q3 | 2.07 Million USD | -16.3% |
| 2003 Q2 | 2.48 Million USD | -60.1% |
| 2003 Q1 | 6.22 Million USD | 234.73% |
| 2003 Q4 | -4.6 Million USD | -321.73% |
| 2003 FY | - USD | -44.56% |
| 2002 FY | - USD | -2.93% |
| 2002 Q1 | 3.18 Million USD | 1.48% |
| 2002 Q2 | 1.53 Million USD | -51.9% |
| 2002 Q3 | 4.57 Million USD | 198.89% |
| 2002 Q4 | 1.85 Million USD | -59.33% |
| 2001 Q1 | 2.66 Million USD | 21.42% |
| 2001 Q2 | 2.5 Million USD | -5.94% |
| 2001 Q3 | 3.18 Million USD | 27.26% |
| 2001 Q4 | 3.13 Million USD | -1.55% |
| 2001 FY | - USD | 63.8% |
| 2000 Q3 | 1.9 Million USD | 35.79% |
| 2000 FY | - USD | 34.78% |
| 2000 Q1 | 1.5 Million USD | 7.14% |
| 2000 Q2 | 1.4 Million USD | -6.67% |
| 2000 Q4 | 2.19 Million USD | 15.24% |
| 1999 Q4 | 1.4 Million USD | 40.0% |
| 1999 Q1 | 600 Thousand USD | 0.0% |
| 1999 FY | - USD | 550.0% |
| 1999 Q2 | 1.5 Million USD | 900.0% |
| 1999 Q3 | 1.59 Million USD | 0.0% |
| 1998 Q1 | 500 Thousand USD | -91.67% |
| 1998 Q2 | 400 Thousand USD | -200.0% |
| 1998 FY | - USD | 366.67% |
| 1998 Q4 | 600 Thousand USD | -85.71% |
| 1998 Q3 | 1.2 Million USD | 800.0% |
| 1997 Q4 | 1.4 Million USD | 700.0% |
| 1997 Q1 | -100 Thousand USD | -20.0% |
| 1997 Q2 | -100 Thousand USD | -16.67% |
| 1997 FY | - USD | -104.76% |
| 1997 Q3 | 300 Thousand USD | 71.43% |
| 1996 Q1 | 1.4 Million USD | -87.65% |
| 1996 Q4 | -5.2 Million USD | -119.23% |
| 1996 Q3 | 1.9 Million USD | 420.0% |
| 1996 Q2 | 900 Thousand USD | -50.0% |
| 1996 FY | - USD | 155.75% |
| 1995 Q4 | -2.1 Million USD | 8000.0% |
| 1995 Q2 | 1.2 Million USD | 107.54% |
| 1995 FY | - USD | -707.14% |
| 1995 Q1 | 1.1 Million USD | -804.55% |
| 1995 Q3 | 400 Thousand USD | -93.33% |
| 1994 Q4 | 200 Thousand USD | -1200.0% |
| 1994 Q3 | 200 Thousand USD | 300.0% |
| 1994 FY | - USD | 46.15% |
| 1994 Q1 | 800 Thousand USD | 116.67% |
| 1994 Q2 | -100 Thousand USD | -112.5% |
| 1993 Q3 | 200 Thousand USD | -50.0% |
| 1993 Q4 | -4.8 Million USD | -2500.0% |
| 1993 Q2 | 400 Thousand USD | -33.33% |
| 1993 Q1 | 600 Thousand USD | 220.0% |
| 1993 FY | - USD | -244.44% |
| 1992 Q1 | 700 Thousand USD | -89.47% |
| 1992 Q4 | -500 Thousand USD | -200.0% |
| 1992 FY | - USD | -45.45% |
| 1992 Q3 | 500 Thousand USD | -28.57% |
| 1992 Q2 | 700 Thousand USD | 16.67% |
| 1991 Q1 | -400 Thousand USD | -100.0% |
| 1991 FY | - USD | 186.84% |
| 1991 Q2 | -800 Thousand USD | -12.5% |
| 1991 Q4 | 600 Thousand USD | 914.29% |
| 1991 Q3 | -900 Thousand USD | 22.22% |
| 1990 Q1 | -100 Thousand USD | 92.59% |
| 1990 Q4 | 100 Thousand USD | 66.67% |
| 1990 FY | - USD | 48.65% |
| 1990 Q2 | -900 Thousand USD | -75.0% |
| 1990 Q3 | -700 Thousand USD | 14.29% |
| 1989 FY | - USD | -37.04% |
| 1989 Q1 | 2.2 Million USD | 122.92% |
| 1989 Q3 | 2.4 Million USD | 9.09% |
| 1989 Q4 | -10.8 Million USD | -550.0% |
| 1989 Q2 | 2.2 Million USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Agilent Technologies, Inc. | 1.67 Billion USD | 100.498% |
| Charles River Laboratories International, Inc. | 1.03 Billion USD | 100.809% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | 100.482% |
| Danaher Corporation | 7.54 Billion USD | 100.111% |
| IQVIA Holdings Inc. | 3.25 Billion USD | 100.256% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | 100.619% |
| Mettler-Toledo International Inc. | 1.18 Billion USD | 100.706% |
| Qiagen N.V. | 650.58 Million USD | 101.283% |
| Revvity, Inc. | 813.25 Million USD | 101.026% |
| Thermo Fisher Scientific Inc. | 10.8 Billion USD | 100.077% |
| Waters Corporation | 1.02 Billion USD | 100.817% |